Document is current
Any future updates will be listed below
-
Authors
Guermazi, Ali
Hayashi, Daichi
Jarraya, Mohamed
Roemer, Frank W.
- License Information
-
More Information
Article History
First Online: 15 September 2023
Declarations
:
: This article does not contain any studies with human participants performed by the authors.
: A.G. has received consultancies from Novartis, Pfizer, AstraZeneca, Coval, ICM, Medipost, TrialSpark, and TissueGene and is President and shareholder of BICL. F.W.R. is the Chief Medical Officer and shareholder of Boston Imaging Core Lab (BICL), a company providing image assessment services. He received consultancies from Grünenthal GmbH. D.H. has received publication royalties from Wolters Kluwer. M.J. has declared no competing interests.
Free to read: This content has been made available to all.
